Alexion Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Alexion Pharmaceuticals's balance sheet done over the years? Its assets were worth $18,103,000,000 last year, which is more than in the previous period. 36% of Alexion Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $6,451,800,000, which means an increase by 3% compared compared to last year.
Debt to Assets
| 2011 | 1394751000 | 260.25M | 18.66% |
|---|---|---|---|
| 2012 | 2613560000 | 642.71M | 24.59% |
| 2013 | 3317696000 | 935.61M | 28.2% |
| 2014 | 4201962000 | 899.94M | 21.42% |
| 2015 | 13133230000 | 4.87B | 37.12% |
| 2016 | 13253000000 | 4.55B | 34.4% |
| 2017 | 13583300000 | 4.69B | 34.53% |
| 2018 | 13931900000 | 4.76B | 34.21% |
| 2019 | 17544600000 | 6.27B | 35.75% |
| 2020 | 18103000000 | 6.45B | 35.64% |
ALXN Balance Sheet (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 2.96B | 2.68B | 1.36B | 584.4M | 966M | 1.01B | 943.99M | 529.85M | 989.50M | 540.86M |
Short term investments | 34.9M | 64M | 198.3M | 889.7M | 327M | 374.90M | 1.01B | 984.99M | 0 | 0 |
Net receivables | 1.40B | 1.24B | 922.3M | 726.5M | 650M | 532.83M | 432.88M | 421.75M | 295.59M | 244.28M |
Inventory | 775.7M | 627.6M | 472.5M | 460.4M | 375M | 289.87M | 176.44M | 102.60M | 94.52M | 81.38M |
Other current assets | 648.6M | 456.1M | 426.4M | 292.9M | 260M | 217.62M | 225.13M | 147.65M | 115.98M | 74.73M |
Total current assets | 5.83B | 5.07B | 3.38B | 2.95B | 2.57B | 2.42B | 2.79B | 2.18B | 1.49B | 941.27M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.46B | 1.16B | 1.47B | 1.32B | 1.03B | 697.02M | 392.24M | 201.10M | 165.62M | 165.85M |
Goodwill | 5.10B | 5.03B | 5.03B | 5.03B | 5.03B | 5.04B | 254.07M | 254.07M | 253.64M | 79.63M |
Intangible assets | 3.00B | 3.34B | 3.64B | 3.95B | 4.30B | 4.70B | 587.04M | 609.71M | 646.67M | 91.60M |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 506.2M | 633.3M | 397.2M | 312.6M | 299M | 255.05M | 137.62M | 62.54M | 38.05M | 12.51M |
Total non-current assets | 12.27B | 12.46B | 10.54B | 10.62B | 10.67B | 10.70B | 1.40B | 1.13B | 1.11B | 453.48M |
Total assets | 18.10B | 17.54B | 13.93B | 13.58B | 13.25B | 13.13B | 4.20B | 3.31B | 2.61B | 1.39B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 150.9M | 103.9M | 24.4M | 15.9M | 37M | 20.50M | 58.83M | 53.80M | 31.26M | 18.76M |
Short term debt | 142.4M | 126.7M | 343.8M | 167.4M | 167M | 175M | 48M | 48M | 48M | 1.44M |
Total current liabilities | 1.62B | 1.19B | 1.17B | 952.5M | 823M | 718.25M | 606.74M | 582.42M | 360.08M | 230.22M |
| Non-current liabilities: | ||||||||||
Long term debt | 2.41B | 2.37B | 2.50B | 2.72B | 2.88B | 3.28B | 9.5M | 65M | 101M | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 775.3M | 622.1M | 699.8M | 652M | 452M | 346.12M | 276.65M | 186.94M | 161.79M | 30.03M |
Total non-current liabilities | 4.82B | 5.07B | 3.59B | 3.73B | 3.73B | 4.15B | 293.20M | 353.18M | 282.62M | 30.03M |
Total liabilities | 6.45B | 6.27B | 4.76B | 4.69B | 4.55B | 4.87B | 899.94M | 935.61M | 642.71M | 260.25M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |